Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01209962 · ClinicalTrials.gov registry record
A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response
A clinical trial, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT01209962 is a clinical trial that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 20 participants.
The verdict
NCT01209962 has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Patients with pancreatic cancer are treated with combinations of surgery, radiation therapy and chemotherapy, depending on the location of the cancer and other individual patient health factors. The goals of therapy are to reduce or eliminate the cancer cells, but without serious damage to normal cells. Investigators at The University of Michigan are conducting a research project, to see if treatment effects on an individual patient's cancer cells can be detected early by new imaging tests in patients with resectable pancreatic cancer undergoing neoadjuvant chemoradiotherapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-05 |
| Est. Completion | 2015-05-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01209962
The ClinicalTrials.gov registry entry for NCT01209962 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01209962 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01209962 about?
NCT01209962 is a clinical study titled "A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response". Patients with pancreatic cancer are treated with combinations of surgery, radiation therapy and chemotherapy, depending on the location of the cancer and other individual patient health factors. The goals of therapy are to reduce or eliminate the cancer cells, but without serious damage to normal ce...
What is the current status of trial NCT01209962?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-05. Estimated completion is 2015-05-26.
Who is sponsoring clinical trial NCT01209962?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.